ArticleTherapeutic advances in hematology2020

Incorporating hematopoietic stem-cell transplantation after second-line carfilzomib-lenalidomide-dexamethasone (KRd).

Ja Min Byun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.